Kit ɗin ganowa na rnase - Masu kera, masana'anta, masu ba da kaya daga China - Alishir
Yanzu muna da ingantacciyar kungiya don magance masu tambaya daga masu siye. Manufarmu shine "100% abokin ciniki na cikakken taimako ta hanyar maganinmu mai girma na sama - inganci, farashi & Sabis ɗinmu" kuma kuyi murna da babban shahara a tsakanin abokan ciniki. Tare da masana'antu da yawa, zamu samar da tsari mai yawa - inhibitor - Kit,E.coli RNA RARIHU, Kite na Trypsin, Kit na Mycoplasma, Kit ɗin Kinamycin saura. Ya kamata a ƙara ƙarin bayani, tuntuɓi mu a kowane lokaci! Kamfaninmu yana tunanin cewa siyarwa ba kawai samun riba ba ne har ma yana nuna al'adun kamfanin mu duniya. Don haka muna aiki tuƙuru don ba ku sabis ɗin da aka gina kuma a shirye ya ba ku farashin gasa a cikin kasuwaKit din RNA, E Corisa Elisa Kit, 293t Kit ɗin HCP, Residuy Times Kit ɗin RNA.
A Afrilu 19, 2023, Jiiangsu Hillssu Hillase Bipharma Co., Ltd. (WANINAFTER ANA GAME DA HANKALIN HANKALI) ya sanar da nadin Dokta Dr. Yuan Zhao a matsayin Babban Jami'in Fasahar ta. Dr. Yuan Zhao zai dauki alhakin sabbin bincike da ci gaba da kuma ESTA
Tabbatar da aminci a cikin ilimin halitta: Matsayi mai mahimmanci na DNA gano Ruwa na Ruwa na 10 - Ganawar filin halittu, za a sami filin rarar kayan tarihi. Tabbatar da aminci da ingancin ilimin halittu, musamman
A ranar 2022 ta Kamfanin Kasuwanci na 2022, an gudanar da shi a ranar 14 ga Disamba, a cikin Suzhou Live na Taro na Kasa da Kasa da Kasa na VB100, an shirya shi tare da Cibiyar Bincike ta Zubahi, da Suzhou High - Kwamitin Gudanar da Tech Tech na Sula Babban taron ya maida hankali
A cikin duniyar binciken kimiyya, daidai da daidaito sune parammata. A lokacin da aiki a cikin filayen kamar nazarin halittu da ilimin tantanin halitta, daidaito na adadin furotin na iya zama mahimmanci musamman. Daya daga cikin mahimman kayan aikin da masu binciken suka dogara da shi
Gabatarwa zuwa gano HCP ta fannin ci gaba da sauri na biopharmautical m, tabbatar da tsarkakakku da amincin kayayyakin warkewa. Daya daga cikin mahimmin fannoni na wannan tsari shine ganowar mai masa kwararru (HCPs), w
A ranar 30 ga Disamba, 2022, "na" 2022 China Biopharmaleuthal Repernancin Insiyawar Insiyawa "a hukumance ta a ranar bude sarkar" na biyu ta kasar Sin da canjin canji. " Jianguwa Hillsene Bio
Manajan tallace-tallace yana da haƙuri sosai, mun saduwa da kimanin kwana uku kafin mu yanke shawarar yin hadin gwiwa a ƙarshe, mun gamsu sosai da wannan haɗin gwiwa!